new glp 1 drug Decoding GLP-1 Weight Loss Medications GLP-1 obesity drugs cleared of

13 Improved Energy Expenditure GLP-1RAs may increase energy expenditure

Consistent with this, certain effectors of the Wnt pathway, including lithium and -catenin, enhance Gcg expression in intestinal but not pancreas-derived cell lines, supposedly via inhibition of the glycogen synthase kinase-3beta (GSK-3beta) [132,133]

doi: 10.1007/s00296-016-3481-8 95 BinduSMazumderSBandyopadhyayU

MIAMI For patients with idiopathic intracranial hypertension, GLP-1 receptor agonists may help with weight loss and play a role in reducing intracranial pressure, according to a speaker at Sunshine Eye & Retina

Neuropsychopharmacology 42, 216241

Bengsch B, Seigel B, Flecken T, Wolanski J, Blum HE, Thimme R